share_log

Does Meinian Onehealth Healthcare Holdings (SZSE:002044) Have A Healthy Balance Sheet?

Does Meinian Onehealth Healthcare Holdings (SZSE:002044) Have A Healthy Balance Sheet?

美年OneHealth Healthcare Holdings(深圳證券交易所:002044)的資產負債表是否良好?
Simply Wall St ·  05/24 20:56

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. As with many other companies Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) makes use of debt. But the more important question is: how much risk is that debt creating?

知名基金經理陸立(Charlie Munger支持)曾說過:“投資風險最大的不是價格波動,而是是否會永久損失資本。”因爲債務常常與企業的破產有關,所以當你評估一個公司的風險時,審視它的資產負債表是非常自然的。與許多其他公司一樣,美年健康(SZSE:002044)有債務。但更重要的問題是:這些債務帶來多少風險?

Why Does Debt Bring Risk?

爲什麼債務會帶來風險?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we think about a company's use of debt, we first look at cash and debt together.

當企業無法用自由現金流或以有吸引力的價格籌措資本來輕鬆履行債務和其他負債時,債務和其他負債就成爲企業面臨的風險。資本主義的一部分是“創造性破壞”的過程,銀行家會毫不留情地清算破產企業。然而,更常見(但仍然代價高昂)的情況是公司必須以低至谷底價格發行股票,永久稀釋股東,以支撐它的資產負債表。話雖如此,最常見的情況是公司合理地管理債務 - 並以自己的優勢爲自己服務。當我們考慮一家公司的債務使用時,首先要看現金和債務。

What Is Meinian Onehealth Healthcare Holdings's Net Debt?

美年健康的淨債務是多少?

You can click the graphic below for the historical numbers, but it shows that as of March 2024 Meinian Onehealth Healthcare Holdings had CN¥3.45b of debt, an increase on CN¥3.15b, over one year. However, because it has a cash reserve of CN¥2.02b, its net debt is less, at about CN¥1.42b.

請點擊下面的圖表查看歷史數據,但它顯示截至2024年3月美年健康擁有34.5億元的債務,相較於一年前增加了3.0億元。但由於它有20.2億元的現金儲備,因此其淨債務減少至約14.2億元。

debt-equity-history-analysis
SZSE:002044 Debt to Equity History May 25th 2024
SZSE:002044的債務股權歷史記錄 於2024年5月25日

How Healthy Is Meinian Onehealth Healthcare Holdings' Balance Sheet?

美年健康的資產負債表情況如何?

We can see from the most recent balance sheet that Meinian Onehealth Healthcare Holdings had liabilities of CN¥7.47b falling due within a year, and liabilities of CN¥2.94b due beyond that. Offsetting these obligations, it had cash of CN¥2.02b as well as receivables valued at CN¥3.02b due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by CN¥5.37b.

我們可以看到最近的資產負債表顯示,美年健康有747億元的負債需要在一年內還清,並且有294億元的負債需要在一年後還清。抵消這些負債,它有20.2億元的現金以及額定爲30.2億元的應收賬款,在12個月內到期。因此,它的負債比其現金和(短期)應收賬款的總和多537億元。

While this might seem like a lot, it is not so bad since Meinian Onehealth Healthcare Holdings has a market capitalization of CN¥16.7b, and so it could probably strengthen its balance sheet by raising capital if it needed to. But we definitely want to keep our eyes open to indications that its debt is bringing too much risk.

雖然這聽起來很多,但並不那麼糟糕,因爲美年健康的市值爲167億元,所以如果需要,它可能可以通過籌集資本來加強其資產負債表。但我們絕對希望密切關注可能會帶來過多風險的債務。

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). Thus we consider debt relative to earnings both with and without depreciation and amortization expenses.

通過查看公司的淨債務與利息、稅、折舊、攤銷前利潤(EBITDA)之比以及它的利息費用(利息覆蓋率)可以衡量一個公司的債務負擔與收益能力。因此,我們考慮將債務與有無計算折舊和攤銷費用的收益相對比。

While Meinian Onehealth Healthcare Holdings's low debt to EBITDA ratio of 0.96 suggests only modest use of debt, the fact that EBIT only covered the interest expense by 3.7 times last year does give us pause. So we'd recommend keeping a close eye on the impact financing costs are having on the business. Notably, Meinian Onehealth Healthcare Holdings's EBIT launched higher than Elon Musk, gaining a whopping 330% on last year. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if Meinian Onehealth Healthcare Holdings can strengthen its balance sheet over time. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

儘管美年健康的債務至EBITDA比率爲0.96,表明它僅在適度使用債務,但去年EBIt僅覆蓋了利息支出3.7倍,這確實讓我們擔憂。因此,我們建議密切關注融資成本對業務的影響。值得注意的是,美年健康的EBIt比Elon Musk高出很多,去年增長了驚人的330%。我們毫不懷疑,從資產負債表中可以了解到關於債務的大部分信息。但最終業務的未來盈利能力將決定美年健康是否能夠隨時間加強其資產負債表。因此,如果您想了解專業人員的想法,您可能會發現這份關於分析師利潤預測的免費報告很有趣。

But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. Happily for any shareholders, Meinian Onehealth Healthcare Holdings actually produced more free cash flow than EBIT over the last three years. That sort of strong cash conversion gets us as excited as the crowd when the beat drops at a Daft Punk concert.

但我們最終的考慮也很重要,因爲公司無法用紙上利潤支付債務,它需要的是硬實力的現金。因此,我們需要清楚地了解EBIt是否帶來對應的自由現金流量。令股東高興的是,過去三年中,美年健康的自由現金流量實際上超過了EBIt。這種強勁的現金轉換讓我們像Daft Punk音樂會上節拍剛落下時的歡呼聲一樣興奮。

Our View

我們的觀點

Meinian Onehealth Healthcare Holdings's conversion of EBIT to free cash flow suggests it can handle its debt as easily as Cristiano Ronaldo could score a goal against an under 14's goalkeeper. But, on a more sombre note, we are a little concerned by its interest cover. It's also worth noting that Meinian Onehealth Healthcare Holdings is in the Healthcare industry, which is often considered to be quite defensive. Looking at the bigger picture, we think Meinian Onehealth Healthcare Holdings's use of debt seems quite reasonable and we're not concerned about it. While debt does bring risk, when used wisely it can also bring a higher return on equity. Above most other metrics, we think its important to track how fast earnings per share is growing, if at all. If you've also come to that realization, you're in luck, because today you can view this interactive graph of Meinian Onehealth Healthcare Holdings's earnings per share history for free.

美年健康將EBIt轉換爲自由現金流的能力表明它可以像Cristiano Ronaldo在14歲以下的門將面前進球一樣輕鬆地處理其債務。但是,更嚴肅的問題是我們對其利息覆蓋率有些擔憂。還應注意的是,美年健康處於醫療保健行業,這通常被認爲是相當穩健的。總體而言,我們認爲美年健康的債務使用似乎相當合理,我們並不擔心。雖然債務確實帶來風險,但明智地使用時也可以帶來更高的股本回報率。在衆多其他指標中,我們認爲跟蹤每股收益增長速度以及是否增長至關重要。如果您也得出了這個結論,那麼今天您可以免費查看美年健康盈利歷史的互動圖表。

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

說到底,有時候更容易集中精力關注根本不需要債務的公司。讀者可以免費訪問零淨債務增長股票列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論